Article Download
Why Is It Important to Measure Potency?
The last decade has seen a rapid development in cell and gene therapies (CGT), which now offer promising solutions for diseases that could not be adequately treated by traditional pharmaceuticals. Potency assays that measure the product-specific biological activity in a disease-relevant system are required by regulatory agencies to grant approval to CGT products. These potency assays provide essential information about efficacy, safety, and activity. Developing these assays has unique challenges, from difficult samples to measuring transgene delivery and validating mechanisms of action.
Explore the common challenges, analytical tools, and importance of selecting appropriate assays for the development of potency assays for cell and gene therapy products including:
- The challenges of assay development
- Selection criteria for analytical tools
- Tips for developing potency assays for cell and gene therapy products
Download the Article
Share a little information with us to access the entire article now.
Content you'll also find interesting
Recommended Features
-
Image
Understanding Potency in Cell and Gene Therapy Development
Read about the current state of the CGT industry and challenges associated with potency assays and measuring product potency throughout the manufacturing process.
-
Image
From Concept to Cure: Using AAV in Gene Therapy
Use this guide to learn about AAV vector challenges, AAV characterization, and addressing developmental hurdles of using vectors in gene therapy.
-
Image
The Role of Droplet Digital™ PCR in Developing Safe and Effective AAV-Based Gene Therapies
Learn how ddPCR technology offers the accuracy to quantify AAV viral titers to support many aspects of quality control for AAV-based gene therapy development.
